Spi-C inhibitors belong to a distinctive chemical class primarily known for their targeted interference with the Spi-C transcription factor. The Spi-C transcription factor, a member of the ETS (E26 transformation-specific) family, plays a crucial role in the regulation of gene expression, particularly within the immune system. Its involvement is integral to the differentiation and function of immune cells, such as T cells and B cells, making it a pivotal factor in the orchestration of immune responses. The inhibitors designed to selectively modulate Spi-C activity act at the molecular level, often through specific interactions with the protein's binding sites or domains.
Spi-C inhibitors exhibit diverse chemical compositions, reflecting the complexity of the Spi-C transcription factor and the need for tailored compounds to achieve effective modulation. Researchers have explored various synthetic routes and medicinal chemistry strategies to design molecules capable of selectively inhibiting Spi-C, avoiding off-target effects on related transcription factors within the ETS family. The development of Spi-C inhibitors represents a promising avenue for understanding the intricate regulatory networks governing immune responses, as well as potential applications in basic research aimed at unraveling the complexities of gene expression in immune cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Disrupts BET bromodomain binding to acetylated histones, potentially altering the expression of genes regulated by SPIC. | ||||||
GSK 525762A | 1260907-17-2 | sc-490339 sc-490339A sc-490339B sc-490339C sc-490339D | 5 mg 10 mg 50 mg 100 mg 1 g | $300.00 $540.00 $940.00 $1680.00 $5900.00 | ||
A BET bromodomain inhibitor that could modify transcriptional programs in which SPIC is involved. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
A glucocorticoid that can regulate immune responses and might modulate SPIC activity indirectly through genomic effects. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that can inhibit calcineurin, potentially affecting SPIC-related immune responses. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which could influence cellular processes and transcription factors like SPIC. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially affecting signaling cascades that involve SPIC. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor which can modulate various signaling pathways, possibly impacting SPIC activity. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
Inhibits Wnt production, which could affect SPIC indirectly by changing cellular signaling related to Wnt. | ||||||
BMS-345541 | 445430-58-0 | sc-221741 | 1 mg | $312.00 | 1 | |
Selectively inhibits IKK, affecting NF-κB signaling, which might influence SPIC-related pathways. | ||||||
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | $130.00 $196.00 $274.00 $512.00 $731.00 $1408.00 $2091.00 | 114 | |
Inhibits STAT3, potentially affecting the transcription of genes in pathways where SPIC is a regulatory factor. | ||||||